SMLA Snapshot

The Stanford Medicine Leadership Academy (SMLA) supports Stanford Medicine’s vision by strengthening the capacity of faculty to shape their future through ethical influencing and effective change management.

Participants are nominated by their departmental leadership for consideration to SMLA, which is an 18-month commitment. Each participant will lead a complex strategic initiative that prototyped future ways of working and serve as a “leadership laboratory.” Other SMLA activities include customized learning with an executive coach, regular peer consultations, monthly learning sessions and retreats, leadership networking and structured leadership interviews. At the midpoint of the program, participants engage in a comprehensive multi-rated leadership assessment.

Cohort 5 is expected to begin in April 2022. 

Program Advisors & Support

Linda M. Boxer, MD, PhD - Vice Dean, Stanford University School of Medicine

Dr. Linda Boxer was appointed Vice Dean of Stanford University School of Medicine in September 2013.

Dr. Boxer obtained her MD and PhD degrees at Stanford University. She was an intern and resident in internal medicine at Stanford and then did a hematology/oncology fellowship at Stanford. She joined the faculty at Stanford in the Division of Hematology, Department of Medicine, and also held a position at the VA Palo Alto Health Care System. Dr. Boxer was the Interim Chair of the Department of Medicine for two years, and she was the Senior Vice Chair of the Department of Medicine for one year.

Since March 2004 she has been the Chief of the Division of Hematology, the director of the Clinical Investigator Pathway (the ABIM research pathway) in the Department of Medicine, and she was the hematology fellowship director for eight years. She has trained and mentored many physicians and physician scientists during this time.

Dr. Boxer’s laboratory investigates the mechanisms of deregulated expression of oncogenes by translation into the immunoglobulin locus in B cells lymphomas. She also maintains a clinical practice in hematology with an interest in hematologic malignancies.